反応式
[Cl:1][C:2]1[N:7]=[C:6]([C:8]2[C:9]([C:18]3[CH:19]=[C:20]([NH:24]C(=O)C(F)(F)F)[CH:21]=[CH:22][CH:23]=3)=[N:10][N:11]3[CH:16]=[C:15]([CH3:17])[CH:14]=[CH:13][C:12]=23)[CH:5]=[CH:4][N:3]=1.[Li+].[OH-].O>C1COCC1>[Cl:1][C:2]1[N:7]=[C:6]([C:8]2[C:9]([C:18]3[CH:19]=[C:20]([NH2:24])[CH:21]=[CH:22][CH:23]=3)=[N:10][N:11]3[CH:16]=[C:15]([CH3:17])[CH:14]=[CH:13][C:12]=23)[CH:5]=[CH:4][N:3]=1参加物
5
実験手順
N-{3-[3-(2-Chloro-4-pyrimidinyl)-6-methylpyrazolo[1,5-a]pyridin-2-yl]phenyl}-2,2,2-trifluoroacetamide (1.70 g, 3.94 mmol) and LiOH (0.50 g, 11.8 mmol) were combined in THF (30 mL) and water (5 mL) and stirred at 40° C. for 3 h. The mixture was cooled, concentrated to remove the THF, and extracted with DCM. The organic phase was concentrated to afford {3-[3-(2-chloro-4-pyrimidinyl)-6-methylpyrazolo[1,5-a]pyridin-2-yl]phenyl}amine which was carried on crude to Step C. ES-LC/MS m/z=336 [M+H]+.
後処理
- temperatureThe mixture was cooled
- concentrationconcentrated
- customto remove the THF
- extractionextracted with DCM
- concentrationThe organic phase was concentrated
出典と根拠
- ORDレコード
- ord-ae4ac85b40f24199855b9947458883cc
- 出典データセット
- uspto-grants-2010_10
- 特許番号
- US07807673B2
関連ノート
読み込み中…